References
- Jarowski C. I., et al. Effect of granulating method on particle size distribution of granules and disintegrated tablets. Drug Dev. Ind. Pharm. 1979; 5(5)479–488
- Krycer I., et al. An evaluation of tablet binding agents. Part I. Solution binders. Powder Technol. 1983; 34: 39–51
- Davies W. L., Gloor W. T. Batch production of pharmaceutical granulations in a fluidized bed. II. Effect of various binders and their concentrations on granulations and compressed tablets. J. Pharm. Sci. 1972; 61(4)618–622
- Danjo K., et al. Influence of granulating fluid properties on physical properties of kneading mass and granules. Chem. Pharm. Bull. 1992; 40(6)1540–1544
- Shiromani P. K., et al. Key variables in dosage form design. Drug Dev. Ind. Pharm. 1991; 17(7)959–974
- Li L. C., Tu Y. H. In vitro drug release from matrix tablets containing a silicone elastomer latex. Drug Dev. Ind. Pharm. 1991; 17(16)2197–2214
- Kristl A., et al. Physicochemical evaluation and statistical assessment of wet granulation. Drugs Made in Germany Jul-Sep, 1994; 37: 78–82
- Sakr A., et al. Study of the effect of disintegrant distribution ratio on tablet characteristics using a central composite design. Eur. J. Pharm. Biopharm. 1993; 39(6)260–263
- Sakr A., et al. Development and evaluation of a monolithic floating dosage form for furosemide. J. Pharm. Sci. Feb, 1994; 83: 239–245
- Peck G. E., et al. Effects of changes in roller compactor parameters on granulation produced by compaction. Drug Dev. Ind. Pharm. 1992; 18(4)469–489
- Upadrashta S. M., et al. Controlled release pellets by extrusion-spheronization. Int. J. Pharm. Oct, 1994; lll: 89–97
- Nagai T., et al. Effect of amount and composition of granulating solution on physical characteristics of tablets. Drug Dev. Ind. Pharm. 1992; 18(10)1099–1110
- Holmquist B., et al. Granulation of a tablet formulation in a high speed mixer, Diosna P25: Influence on intragranular porosity and liquid saturation. Drug Dev. Ind. Pharm. 1987; 13(6)1069–1079
- Hussain A., et al. Application of neural computing in pharmaceutical product development. Pharm. Res. 1991; 8(10)1248–1252
- Erb R. J. Introduction to backpropagation neural network computation. Pharm. Res. 1993; 10(2)165–170
- Kane A., Hussain A. Artificial neural networks-overview. Indian Drugs 1993; 30(5)168–178
- Blackwood A., Dole E. J. Cycloserine dosing using artificial intelligence. presented at ASHP Midyear Clinical Meeting. December, 1992, P130E
- Veng Pedersen P., Modi N. B. Neural networks in pharmacodynamic modeling: Is current modeling practice of complex kinetic systems at a dead end?. J. Pharmacokinet. Biopharm. 1992; 20(8)397–412
- Veng Pedersen P., Modi N. B. Application of neural networks to pharmacodynamics. J. Pharm. Sci. 1993; 82(9)918–926
- Hussain A., et al. Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data. Pharm. Res. 1993; 10(3)466–469
- Hussain A., et al. Application of neural computing in pharmaceutical product development: Computer aided formulation design. Drug Dev. Ind. Pharm. 1994; 20(10)1739–1752
- Murtoniemi E., et al. Advantages by the use of neural networks in modeling the fluidized granulation process. Int. J. Pharm. 1994; 108(8)155–164
- Murtoniemi E., et al. Effect of neural network topology and training end point in modeling the fludized bed granulation process. Int. J. Pharm. 1994; 110(9)101–108
- Kesavan J. Approaches to the modeling of tablet processing and stability of solid dosage forms. Ph.D. thesis, Purdue University. 1994
- Cybenko B. Approximation by superposition of a sig-moidal function. Mathematical Control Signal Systems 1989; 2: 303